(Reuters) -Several major drugmakers are counting on their manufacturing flexibility to counter potential disruptions from ...

Welcome to the April issue of Contract Pharma. This month’s edition highlights critical trends and challenges shaping the pharma manufacturing and development landscape, highlighting new regulatory ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Levies on those commodities could make prices rise without encouraging domestic production ... While the drug industry was ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

As pharma giants line up one after another to tout their investment plans in the U.S., Regeneron is adopting a different tack ...

Effective April 5, the United States imposed a 10% baseline tariff on imports from nearly all countries, excluding products from Canada and ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...

The Minister of Trade, Agribusiness, and Industry, Elizabeth Ofosu-Adjare, has announced the government’s plan to launch a ...